Dose Escalation Study Design Example Record

Dose Escalation Study Design Example 2 of 22 September 2019 (With Results) 100 mg/m^2, via intravenous catheter (IV), twice a day for 4 weeks for the first cohort. Successive cohorts will be given doses of 125 and 150 mg/m^2 twice a day. Dose escalation will continue until the maximum-tolerated dose (MTD), defined as one dose level below

Design, Study, Example, Dose, Escalation, Dose escalation study design example, Dose escalation study design example 2

Download Dose Escalation Study Design Example Record

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Documents from same domain

Protocol Registration and Document Upload Quality Control ...

prsinfo.clinicaltrials.gov

ClinicalTrials.gov Protocol Registration and Document Upload Quality Control Review Criteria 27 June 2018 Page 5 of 10 3. The Brief Summary clearly states the study’s hypothesis or the purpose of the study …

Study

Cross-Over Study Design Example (With Results)

prsinfo.clinicaltrials.gov

ClinicalTrials.gov is a service of the National Institutes of Health. Cross-Over Study Design Example 1 of 17 September 2019 (With Results) Cross-Over Study Design Example (With Results)

Design, Study, Cross, Example, Over, Cross over study design example

Parallel Study Design Example (With Results)

prsinfo.clinicaltrials.gov

ClinicalTrials.gov is a service of the National Institutes of Health. Parallel Study Design Example 1 of 19 August 2019 (With Results) Parallel Study Design Example (With Results)

With, Design, Study, Example, Parallel, Parallel study design example

Checklist for Evaluating Whether a Clinical Trial or Study ...

prsinfo.clinicaltrials.gov

Jun 27, 2018 · 42 CFR 11.22(b) sets forth an approach for determining whether or not a clinical trial initiated on or after January 18, 2017, meets the regulatory definitions of an applicable device clinical trial and an applicable drug clinical trial by identifying a series of specific criteria and the corresponding ClinicalTrials.gov registration data elements.

Determining, Whether, Determining whether

Outcome Measure Template Examples - ClinicalTrials.gov

prsinfo.clinicaltrials.gov

Outcome Measure Template Examples Author: National Library of Medicine Subject: Outcome Measure Template, examples for data entry Keywords: Data Entry Table, template, examples, ClinicalTrials.gov Created Date: 1/29/2017 4:47:19 PM

Outcome, Measure, Template, Outcome measure template

Protocol Registration Template for Interventional Studies

prsinfo.clinicaltrials.gov

Jan 18, 2017 · Provide bulleted lists (one criterion per bullet) below the headers "Inclusion Criteria" and "Exclusion Criteria." * Eligibility Criteria: PROTOCOL REGISTRATION TEMPLATE. Page . 5 of 7 . INTERVENTIONAL STUDY . Study Chair Study Chair . enrolled) 11. CONTACTS, LOCATIONS, AND INVESTIGATOR INFORMATION *

Lists, Registration, Template, Protocol, Bulleted, Bulleted lists, Protocol registration template